Metronidazole vs Placebo as Adjuncts to Periodontal Surgery for Patients Positive to Porphyromonas Gingivalis
Status:
Completed
Trial end date:
2018-01-15
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine whether the use of a systemic antimicrobial
(metronidazole) as an adjunct to periodontal surgery provides additional clinical and
microbiological beneficial effects compared to periodontal surgery alone plus a placebo, in
patients with non treated periodontitis (stage III and IV) positive to Porphyromonas
gingivalis.